Simris Alg
Simris Group CEO, Julian Read, answers questions from Finwire regarding company strategy and its ongoing Rights Issue
Julian Read, CEO for Simris Group AB clarifies the strategic focus for the Company, its business model for its Antibody Drug Conjugate (ADC) products and how funds from the ongoing capital raising will be prioritised during an interview with Finwire.
The interview can be viewed at www.youtube.com/watch?v=ogonDAE4UuY&t=12s.
Datum | 2023-08-08, kl 14:15 |
Källa | MFN |
Bifogade filer

Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet